Thomas Insel shares his thoughts on #mentalhealth at the #STATBreakthrough Summit
Thomas Insel, MD
vannahealth
Peter Chin-Hong on the disrespect and threats he endured during the #COVID19 pandemic.
Peter Chin-Hong MD
UCSF School of Medicine
#STATBreakthrough
This morning, Tom and Emily had the honor of kicking off #STATBreakthrough to discuss ‘Living With a Cure’ beyond CAR-T, the Whitehead’s book Praying For Emily Book, and birthday cake vs. ice cream. (Spoiler: ice cream wins)
Thank you Matthew Herper & STAT for the invitation!
“It’s extraordinary that in this day and age, you still have the incidence of HIV increasing around the world, and even in this country,” Gilead CEO Daniel O’Day said at #STATBreakthrough Summit. trib.al/PjyL3Ck
Joel Dudley, Donna Ginther, Sofie Kleppner and Rayyan Gorashi, MS will discuss academia's mass exodus.
#STATBreakthrough
“Wouldn't it be amazing if in the future, you could have an injectable or even an oral delivery of gene editing? … Right now that sounds kind of like sci fi, but I think in the future that will be possible.”
Jennifer Doudna at #STATBreakthrough
Learning from Verily #CEO Stephen Gillett and #CMO Amy Abernethy to intersect #humanity , #humility , #technology and #innovation to bring better #personalized healthcare for our patients STAT #STATBreakthrough summit.
AI in Health Care: What are the Risks?
— This panel has thoughts
Suchi Saria Bayesian Health
#STATBreakthrough #ChatGPT #AI
Now that I’ve caught a moment to breathe…I can’t wait to serve on this panel alongside such incredible minds at #STATBreakthrough !
Thank you so much Jonathan Wosen, Ph.D. and the STAT team for all of the efforts put towards organizing this session!
Verily’s New Direction laid out at #STATBreakthrough STAT
Dr. Amy Abernethy: Research and care under a transparent patient centricity product development using longitudinal data. Bringing research to all people.
Stephen Gillett : Drive behavior for stakeholders to…
Are Cancer-Detecting Blood Tests Ready for Prime Time?
Researchers are finding ways to detect #cancer early with a simple blood test using DNA sequencing. How do we know when these tests are ready for wide use?
We ask: Peter B. Bach, MD Rita Redberg Gautam Kollu Tina Clarke GRAIL
Cancer early detection using DNA alone may not be sufficient to detect cancer with high sensitivity+specificity at early stages.
How are companies such as GRAIL Exact Sciences Freenome Delfi Diagnostics Guardant Health Caris Life Sciences thinking about RNA?
#STATBreakthrough
Amazing to hear from Dr. Doudna Doudna Lab, The Nobel Prize Laureate for #CRISPR and President at Innovative Genomics Institute - very exciting about opportunities ahead in gene editing 👏 🧬 👩🔬 they have spun out already 17 companies!! #STATBreakthrough STAT
At Every Cure, David Fajgenbaum, MD uses a unique AI tool to figure out potential matches between FDA-approved drugs and diseases without known treatments.
Read more of his interview from #STATBreakthrough Summit here: trib.al/A90e786
AI in Health Care: What are the Risks?
The ability of AI models to answer medical questions & quickly summarize information has awakened the world to its potential. But they also commit grievous errors & make things up.
Ft. Nigam Shah Suchi Saria Connor Landgraf
#STATBreakthrough
Exciting day 2 at #STATBreakthrough with The Nobel Prize Laureate Jennifer Doudna Doudna Lab + Stephen Gillett & Amy Abernethy Verily!
And great to meet Katherine MacPhail + UCSC SciCom alums Jonathan Wosen, Ph.D. & Nicholas St. Fleur!
Thanks Matthew Herper & STAT team for a great event!